{"id": "1371370847001268226", "creation": 1615795263.0, "user_id": "1239578106039582726", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Despite its #COVID19 #vaccine success, #Pfizer has fallen off its all-time high of $42.56 a share and into very attractive valuation, says @themotleyfool\nWould you buy the dip? Trade with the first regulated hybrid broker at https://t.co/aY2rHVXCRw\n\n*Trading carries risk of loss https://t.co/qooeuz5vKN", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#PFIZER"]}